Ohio State Cancer Researcher Receives Carcinogenesis Award

July 06, 2012
Ohio State Cancer Researcher Receives Carcinogenesis Award

COLUMBUS, Ohio – Dr. Carlo Croce, chair of the department of molecular virology, immunology, and medical genetics; and director of Human Cancer Genetics at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, received the 2012 Anthony Dipple Carcinogenesis Award.

The award, sponsored by Oxford University Press, is given to individuals who have added major contributions to research in how cancer develops, the field of study called carcinogenesis. The award will be presented at the 2012 biennial meeting of the European Association for Cancer Research (EACR) in Barcelona, Spain on July 7-10.

Croce, also the John W. Wolfe Chair in Human Cancer Genetics, recently received one of the nation's highest honors with his induction as a member of the Institute of Medicine of the National Academies.

Croce, a member of the National Academy of Sciences in the United States and the Accademia Nazionale delle Scienze detta dei XL in Italy, has received numerous awards for cancer research. He is principal investigator on 11 federal research grants and has more than 900 peer-reviewed, published research papers.

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 41 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only seven centers funded by the NCI to conduct both phase I and phase II clinical trials. The NCI recently rated Ohio State's cancer program as "exceptional," the highest rating given by NCI survey teams. As the cancer program's 210-bed adult patient-care component, The James is a "Top Hospital" as named by the Leapfrog Group and one of the top 20 cancer hospitals in the nation as ranked by U.S. News & World Report.

###

Contact: Eileen Scahill, Wexner Medical Center Public Affairs and Media Relations, 614-293-3737, or Eileen.Scahill@osumc.edu

Contact Media Staff

Amanda Harper

Director of Media Relations


614-685-5420 (direct)


614-293-3737 (main)


Amanda.Harper2@osumc.edu


Media staff are available by calling 614-293-3737 Monday through Friday between 8 a.m. and 5 p.m.

 

If after hours, please call 614-293-8000 (ask the operator to page the hospital administrative manager).

Latest News

New Clinical Trial Aims to Reprogram Cells to Attack a Specific Relapsed Blood Cancer

An upcoming clinical trial at The James aims to reprogram a patient’s immune cells to attack a specific relapsed blood cancer, called multiple myeloma. The idea is to “super-charge” the patient’s immune...

Read More

NCCN Publishes New Guidelines for Smoking Cessation, Effort Led by Ohio State Oncologist

To meet the needs of patients who are smokers at the time of a cancer diagnosis, the National Comprehensive Cancer Network has published smoking cessation guidelines. Ohio State's Peter Shields, MD...

Read More

Molecules in Prostate Tumors Might Predict Whether RT Can Help Prevent Recurrence

A new study has identified a group of molecules in prostate-cancer cells that doctors might one day use to distinguish which patients should be treated with radiation therapy if rising PSA levels...

Read More